A Study to Test Different Doses of BI 456906 in Patients With Obesity

NCT03591718 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

131

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: BI 456906
DRUG: Placebo

Sponsor

Boehringer Ingelheim